Physicians use mechanical ventricular assist devices to support patients through periods of hemodynamic instability. Ventricular assist devices used for short-term support are usually brought into the patient through minimally invasive methods, mostly by accessing blood vessels in the groin (percutaneous delivery). In particular, these catheter-based devices are used in cardiogenic shock patients and patients undergoing...
Author: Nadisign
High Risk PCI
Percutaneous coronary procedures allow the minimally invasive treatment of coronary artery disease. These procedures are a mainstay of interventional cardiology and usually uneventful. However, some procedures carry an elevated risk either due to the physiological or anatomical condition of the patient, or the complexity of a particular procedure, and are deemed high-risk procedures (high-risk PCI)....
Cardiogenic Shock
Cardiogenic shock is a medical emergency characterized by the inability of the heart to pump sufficient blood volume for adequate organ and tissue perfusion. Cardiogenic shock carries a dire prognosis with a high in-hospital mortality. Ventricular assist devices are used to support the heart in cardiogenic shock patients, with the aim of unloading the heart...
CardiacBooster accepted into Medtech Innovator Accelerator Class of 2021.
The CardiacBooster team is excited to announce that the company has been accepted into the Medtech Innovator Accelerator Class of 2021. The prestigious program features the industry’s most transformative device, diagnostic, and digital health technologies from around the globe, selected from a pool of global applicants by a panel of 200 industry judges. As part...
CardiacBooster genomineerd
Cum sociis natoque penatibus et magnis dis parturient montesmus. Pro vel nibh et elit mollis commodo et nec augueique
CardiacBooster wins Academic Start-Up Competition prize
Cum sociis natoque penatibus et magnis dis parturient montesmus. Pro vel nibh et elit mollis commodo et nec augueique